Dr. Meredith Lightfoot, M.D.
What this data tells you about Dr. Lightfoot
Dr. Meredith Lightfoot is an urology physician in Plano, TX, with 19 years in practice. Based on federal Medicare data, Dr. Lightfoot performed 16,533 Medicare services across 3,851 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lightfoot received a total of $7,532 from 50 pharmaceutical and/or device companies across 390 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lightfoot is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit | 10,800 | $5 | $13 |
| Automated urinalysis | 1,493 | $2 | $5 |
| Office visit, established patient (20-29 min) | 854 | $64 | $183 |
| Bladder ultrasound after voiding | 435 | $8 | $22 |
| Urine culture, bacterial colony count | 391 | $8 | $16 |
| Urine culture, bacterial identification | 379 | $8 | $16 |
| Office visit, established patient (30-39 min) | 323 | $91 | $259 |
| Bacterial culture, aerobic | 204 | $8 | $16 |
| New patient office visit (45-59 min) | 203 | $116 | $336 |
| Antibiotic sensitivity test | 199 | $8 | $17 |
| Catheterization for collection of specimen, single patient, all places of service | 192 | $8 | $16 |
| New patient office visit (30-44 min) | 164 | $79 | $226 |
| Ceftriaxone antibiotic injection | 119 | $0 | $1 |
| Diagnostic exam of bladder and urethra using an endoscope | 113 | $173 | $495 |
| Exam with injections of chemical for destruction of bladder using an endoscope | 98 | $296 | $796 |
| Urinalysis with microscopic exam | 85 | $3 | $6 |
| Blood draw (venipuncture) | 74 | $8 | $17 |
| Injection, garamycin, gentamicin, up to 80 mg | 74 | $2 | $6 |
| PSA test (prostate cancer screening) | 54 | $18 | $37 |
| Drug injection, under skin or into muscle | 50 | $10 | $29 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 46 | $17 | $48 |
| Simple insertion of temporary bladder tube | 41 | $45 | $126 |
| Hospital follow-up visit, low complexity | 29 | $39 | $100 |
| Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | 27 | $10 | $56 |
| Complex measurement of pressure of urine flow in bladder with voiding pressure studies | 21 | $197 | $544 |
| Insertion of device into abdomen with pressure and urine flow rate study | 21 | $115 | $318 |
| Office visit, established patient (10-19 min) | 19 | $35 | $115 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 13 | $65 | $166 |
| Simple bladder irrigation and/or instillation | 12 | $59 | $156 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Lightfoot is a mixed practice specialist, with above-average Medicare volume (top 5% in TX), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Lightfoot experienced with botox injection, per unit?
Does Dr. Lightfoot receive payments from pharmaceutical companies?
How do Dr. Lightfoot's costs compare to other urology physicians in Plano?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology